Private limited company · Oslo
ARCORAL PHARMA AS
ActiveResearch and experimental development on natural sciences and engineering (72.100)
The life line 2011–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2020: NOK 2k.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
ARCORAL PHARMA AS is a private limited company in Oslo, founded in 2011, in the industry research and experimental development on natural sciences and engineering. The chief executive is Christian Fredrik Johansen, and the chair of the board is Vibeke Johansen. In 2025 the company had NOK 0 in operating revenue and a net profit of NOK −52k. The largest owner is MARNIC AS with 10.0%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 11 Aug 2026
- New address Reistadlia 32 → Gabels gate 7
- New address 3312 → 0301
- New address LIER → OSLO
- New address 3425 → 0272
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteOperating loss three years running, 2023–2025
- Note2 of 4 on the board are new in the last 12 months
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 0 in 2025
Revenue
NOK 0
— from 2024
20232025
Operating profit
NOK −81k
+10.3% from 2024
20232025
Net profit
NOK −52k
+26.0% from 2024
20232025
Equity
NOK 230k
−18.4% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2017
Of every krone of operating revenue in 2017:
- Other operating costs 12%
- Left as operating result 88%
Of the net profit for 2017, NOK 1.0m stayed in the company. The rest, NOK 2.2m, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 22.6%
- ARCORAL PHARMA AS, 2020
- Industry median, assumed: NOK 1.2m · 1.3% · 47.7%
Equity NOK 390k23% of the assets (NOK 1.7m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 500 companies in 72.100 Research and experimental development on natural sciences and engineering, not stated by the source.
Finances
§ 06 Accounts
15 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 0 | 0 | 0 | |
| Operating profit | −81 | −90 | −18 | |
| Profit before tax | −67 | −90 | −18 | |
| Net profit | −52 | −70 | −14 | |
| Total assets | 243 | 310 | 406 | |
| Equity | 230 | 282 | 352 | |
| Liabilities | 14 | 28 | 54 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 15 years →
Management and ownership
§ 07 Officers
6 officers now
- REGNSKAPSFØRER1 AUTORISERT REGNSKAPSFØRERSELSKAP ASAccountant
- Christian Fredrik JohansenChief executive since 2026
- Vibeke JohansenChair of the board since 2026
- Christian Fredrik JohansenBoard member since 2016
- Rolf Hilmar NicolaissenBoard member since 2014
- Lene JohansenBoard member since 2026
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 6 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
Styrets leder alene.
May sign for the company:
Styrets leder alene.
Procuration: none registered.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 25 Aug 2026
Management and ownership
§ 09 Owners
1 shareholder · largest 10.0%
| Owner | Share |
|---|---|
| MARNIC AS | 10.0% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
18 connections
- Person
- Company
4 people link ARCORAL PHARMA AS to 16 other companies: Rolf Hilmar Nicolaissen 9, Lene Johansen 3, Christian Fredrik Johansen 2 and Vibeke Johansen 2.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
38 since 2015
Events per year
20152026
Since 2015: 48 announcements and 5 register changes. Most happened in 2015 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 38 events →
Events and registers
§ 14 Notices
48, latest 10 Aug 2026
- Forretningsadresse
- Signatur
- Styre
Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 48 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 2 of 7
- The Central Coordinating RegisterRegistered 9 Mar 2011
- VATNot registered
- The Register of Business EnterprisesRegistered 9 Mar 2011
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Utvikling, lisensiering og salg av famasøytiske produktrettigheter og produkter hva hermed står i forbindelse, samt investering i andre selskaper.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 72.100
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of ARCORAL PHARMA AS?
Christian Fredrik Johansen, since 2026. § 07 - Who owns ARCORAL PHARMA AS?
1 shareholder. It is MARNIC AS with 10.0%. § 09 - What was the revenue in 2025?
NOK 0 in the company. § 06 - Who can sign for ARCORAL PHARMA AS?
Styrets leder alene. § 08 - Where is ARCORAL PHARMA AS based?
Gabels gate 7, 0272 Oslo. - When was ARCORAL PHARMA AS founded?
24 Feb 2011, registered in the Register of Business Enterprises 9 Mar 2011. § 16
The answers come from the sections linked to, with their sources.